New Brunswick has become the fifth province to have signed an agreement with Health Canada under the National Strategy for Drugs for Rare Diseases. This commitment of over $32 million will help improve access to selected new drugs for rare diseases, and support enhanced access to existing drugs, early diagnosis, and screening.